Inhibition of S6 Kinase activity for the treatment of insulin resistance

This invention provides screening methods for agents effective in treating insulin resistance through specific inhibition of S6 kinase 1 activity. Also provided are methods of treating insulin resistance by administering an effective amount of an inhibitor specific for S6 kinase 1


Year:
2005
Note:
Applicant(s): Novartis Forschungsstiftung [CH]
Other identifiers:
EPO Family ID: 34216100
Laboratories:




 Record created 2009-04-20, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)